# FDA Inspection 1059878 - CorneaGen - Richmond - May 31, 2018

Source: https://www.keypedia.com/records/fda_inspections/corneagen-richmond/509a259e-e017-496b-ba11-480c6232fb49
Source feed: FDA_Inspections

> FDA Inspection 1059878 for CorneaGen - Richmond on May 31, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1059878
- Company Name: CorneaGen - Richmond
- Inspection Date: 2018-05-31
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1059878 - 2018-05-31](https://www.keypedia.com/records/fda_inspections/corneagen-richmond/78247ae5-77b6-4edd-a022-6a5d0698bed5)
- [FDA Inspection 974353 - 2016-05-12](https://www.keypedia.com/records/fda_inspections/corneagen-richmond/22f5740d-53c5-42f6-aecd-5164bb2ce585)
- [FDA Inspection 823345 - 2013-02-12](https://www.keypedia.com/records/fda_inspections/corneagen-richmond/6378d570-ee2b-4052-a9c9-f506433a31f1)
- [FDA Inspection 729194 - 2011-06-13](https://www.keypedia.com/records/fda_inspections/corneagen-richmond/7fefc635-1cbd-4d8e-afec-d941322c6b37)

Company: https://www.keypedia.com/companies/corneagen-richmond/75dc924b-7b44-4876-8e60-c6227fcf6bc4

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d